SurgePays (SURG) Competitors $1.55 -0.03 (-1.90%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends SURG vs. TELA, SRTS, ECOR, FONR, LNSR, GUTS, MLSS, MGRM, EDAP, and HYPRShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include TELA Bio (TELA), Sensus Healthcare (SRTS), electroCore (ECOR), FONAR (FONR), LENSAR (LNSR), Fractyl Health (GUTS), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. SurgePays vs. TELA Bio Sensus Healthcare electroCore FONAR LENSAR Fractyl Health Milestone Scientific Monogram Orthopaedics Edap Tms Hyperfine SurgePays (NASDAQ:SURG) and TELA Bio (NASDAQ:TELA) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, community ranking, institutional ownership, profitability, dividends and analyst recommendations. Does the MarketBeat Community favor SURG or TELA? SurgePays received 111 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 69.11% of users gave SurgePays an outperform vote. CompanyUnderperformOutperformSurgePaysOutperform Votes17069.11% Underperform Votes7630.89% TELA BioOutperform Votes5974.68% Underperform Votes2025.32% Do institutionals & insiders have more ownership in SURG or TELA? 6.9% of SurgePays shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 29.4% of SurgePays shares are held by insiders. Comparatively, 6.0% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is SURG or TELA more profitable? SurgePays has a net margin of -27.39% compared to TELA Bio's net margin of -60.49%. SurgePays' return on equity of -55.63% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets SurgePays-27.39% -55.63% -43.61% TELA Bio -60.49%-556.18%-63.13% Do analysts recommend SURG or TELA? SurgePays currently has a consensus target price of $8.50, suggesting a potential upside of 448.39%. TELA Bio has a consensus target price of $9.25, suggesting a potential upside of 243.87%. Given SurgePays' higher probable upside, analysts clearly believe SurgePays is more favorable than TELA Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SurgePays 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SURG or TELA? In the previous week, SurgePays and SurgePays both had 1 articles in the media. SurgePays' average media sentiment score of 0.96 beat TELA Bio's score of 0.94 indicating that SurgePays is being referred to more favorably in the media. Company Overall Sentiment SurgePays Positive TELA Bio Positive Which has more volatility and risk, SURG or TELA? SurgePays has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500. Which has higher earnings and valuation, SURG or TELA? SurgePays has higher revenue and earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgePays$137.14M0.23$20.62M-$1.13-1.37TELA Bio$58.45M1.81-$46.66M-$1.69-1.59 SummarySurgePays beats TELA Bio on 12 of the 17 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ ExchangeMarket Cap$33.87M$16.92B$26.82B$8.96BDividend YieldN/A8.45%2.79%4.04%P/E Ratio-1.3717.63226.9516.84Price / Sales0.234.413,249.4179.09Price / Cash1.318.4534.2935.97Price / Book0.922.718.394.79Net Income$20.62M$788.23M$672.79M$224.99M7 Day Performance-7.74%0.86%2.04%1.50%1 Month Performance-9.88%-1.79%5.09%4.68%1 Year Performance-72.81%5.26%26.53%20.92% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays3.5802 of 5 stars$1.55-1.9%$8.50+448.4%-76.5%$33.87M$137.14M-1.3740Short Interest ↓TELATELA Bio2.7504 of 5 stars$2.82+0.4%$9.25+228.0%-59.7%$111.07M$68.65M-1.67120SRTSSensus Healthcare3.3642 of 5 stars$6.39-2.3%$12.50+95.6%+131.0%$104.73M$41.31M11.2140Short Interest ↑ECORelectroCore3.4032 of 5 stars$15.27-7.7%$25.00+63.7%+136.6%$100.10M$23.33M-8.3450Short Interest ↓Positive NewsFONRFONAR0.88 of 5 stars$15.30+0.5%N/A-19.9%$96.82M$102.01M10.93480Short Interest ↑LNSRLENSAR0.7089 of 5 stars$8.00-3.0%$8.00+115.5%$92.92M$48.87M-5.48110Positive NewsGUTSFractyl Health1.6281 of 5 stars$1.92+3.8%$22.00+1,045.8%N/A$92.35M$97,000.00-0.16102Short Interest ↑Positive NewsGap UpHigh Trading VolumeMLSSMilestone Scientific0.7138 of 5 stars$1.11-5.9%$1.25+12.6%+102.0%$86.46M$8.88M-15.8530MGRMMonogram Orthopaedics3.5072 of 5 stars$2.42-3.2%$4.00+65.3%-21.2%$83.04M$364,999.00-5.1528Short Interest ↓Positive NewsEDAPEdap Tms3.4217 of 5 stars$2.10flat$19.00+804.8%-62.3%$77.92M$63.41M-3.23307Short Interest ↓HYPRHyperfine2.8114 of 5 stars$0.99+5.4%$1.60+61.6%-0.4%$72.22M$13.26M-1.74190Positive News Related Companies and Tools Related Companies TELA Bio Competitors Sensus Healthcare Competitors electroCore Competitors FONAR Competitors LENSAR Competitors Fractyl Health Competitors Milestone Scientific Competitors Monogram Orthopaedics Competitors Edap Tms Competitors Hyperfine Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SURG) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURG Stock Alerts